No profile data available.
Oragenics, Inc. (OGEN) is a healthcare company in the brain and nerve treatment drugs industry, based in Lakewood Ranch, United States, with about 3 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of -$9.84 million. In Q1 2026 (the quarter ended March 31, 2026) revenue was $0. Its market capitalization was $1.98 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a development-stage company, engages in the research and development of nasal delivery pharmaceutical therapies neurological conditions and infectious diseases in the United States.
Oragenics reported $0 in revenue for fiscal year 2025. In Q1 2026 revenue was $0.
$1.98 million as of October 9, 2026.
Listed companies of a similar size in the same industry (brain and nerve treatment drugs) include Jupiter Neurosciences, Inc. (JUNS), Psyence Biomedical Ltd. (PBM), Silo Pharma, Inc. (SILO), Protagenic Therapeutics, Inc. (PTIX).